Medical Technology - Turkey

Turkey

Turkey is expected to experience significant growth in the Medical Technology market market, with projected revenue reaching US$6.06bn in 2024.
Among the various markets within this market, Medical Devices hold the largest share, with a projected market volume of US$5.10bn in the same year.
This sector is expected to maintain a steady annual growth rate of 4.85%, resulting in a market volume of US$7.68bn by 2029.
When compared to global numbers, it is worth noting that the United States is anticipated to generate the highest revenue in the Medical Technology market market, amounting to US$211.10bn in 2024.
This demonstrates the dominance of the US market in this industry.
Turkey is experiencing a surge in demand for medical technology, driven by the country's growing healthcare sector and increasing investments in research and development.

Key regions: United States, Germany, China, Japan, France

Market

Region

Region comparison

Currency

Analyst Opinion

The Medical Technology market in Turkey is experiencing significant growth and development.

Customer preferences: Customers in Turkey are increasingly demanding advanced and innovative medical technologies to improve patient outcomes and enhance healthcare services. They are seeking state-of-the-art medical devices and equipment that can provide accurate diagnoses, effective treatments, and minimize the need for invasive procedures. Additionally, there is a growing focus on personalized medicine and digital health solutions, as patients are becoming more proactive in managing their own health.

Trends in the market: One of the key trends in the Medical Technology market in Turkey is the adoption of telemedicine and remote patient monitoring solutions. This trend has been accelerated by the COVID-19 pandemic, as healthcare providers are looking for ways to deliver care to patients without physical contact. Telemedicine allows for remote consultations, diagnosis, and monitoring, enabling patients to receive timely and efficient healthcare services from the comfort of their homes. This trend is expected to continue as it offers convenience and accessibility for both patients and healthcare providers. Another trend in the market is the increasing use of artificial intelligence (AI) and machine learning (ML) in medical technology. AI and ML algorithms are being utilized to analyze large amounts of medical data, enabling healthcare professionals to make more accurate diagnoses and treatment decisions. These technologies are also being used to develop predictive models that can identify potential health risks and intervene early, leading to better patient outcomes. The integration of AI and ML in medical technology is expected to drive further advancements and improve healthcare delivery in Turkey.

Local special circumstances: Turkey has a rapidly growing aging population, which is driving the demand for medical technology. As the elderly population increases, there is a greater need for medical devices and equipment that can address age-related health issues and provide effective care. This includes devices for monitoring chronic conditions, mobility aids, and assistive technologies. The government is also investing in healthcare infrastructure and promoting the development of medical technology to meet the needs of the aging population.

Underlying macroeconomic factors: The Turkish government has been implementing healthcare reforms and investing in the healthcare sector, which has created a favorable environment for the growth of the Medical Technology market. The government's focus on improving healthcare services and increasing access to quality healthcare has led to increased spending on medical technology. Additionally, Turkey's strategic location between Europe, Asia, and the Middle East makes it an attractive market for international medical technology companies looking to expand their presence in the region. In conclusion, the Medical Technology market in Turkey is experiencing growth and development driven by customer preferences for advanced and innovative medical technologies, the adoption of telemedicine and AI, the aging population, and government initiatives to improve healthcare services. These factors contribute to a positive outlook for the market, with opportunities for both local and international companies to thrive in the Turkish healthcare sector.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.